Ackermans & van Haaren: Funding, Team & Investors | Startup Intros

Loading organizations...

Ackermans & van Haaren: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 19, 2026	Medikabazaar	$55.1M Other Equity	—	British International Investment, Creaegis, HealthQuad, Rebright Partners
Dec 15, 2025	DISCO Pharmaceuticals	$42.3M Seed	Lenny Van Steenhuyse, NRW.BANK	AbbVie Ventures, M Ventures, Panakes Partners, Sofinnova Partners
Sep 4, 2025	MRM Health	$64.1M Series B	Jean-Patrick Hennebelle	Raf Moons, Goedele Ertveldt, Julian Zachmann, OMX Ventures, Qbic II
Jul 1, 2024	Confo Therapeutics	$65.0M Series B	Ackermans & van Haaren	BGV (BioGeneration Ventures)
Jan 1, 2024	Vico Therapeutics	$72.0M Series B	Piet Dejonghe	Canaan Partners, EQT Life Sciences, Hercules Capital, Kurma Partners, Polaris Partners, Pontifax Venture Capital
Aug 25, 2022	AstriVax	$29.9M Seed	Caroline Goddeeris, Shelley Margetson	BNP Paribas Fortis Private Equity, Flanders Future Tech Fund, KU Leuven, Merieux Equity Partners, Thuja Capital
Jul 27, 2020	Indigo Diabetes	$44.4M Series B	Jan Van den Bossche	Capricorn Venture Partners, imec.xpand, QBICII, Titan Baratto
Jul 30, 2019	Biotalys	$39.0M Series C	—	Piet Bevernage, Agri Investment Fund, Biovest, Gimv, K&E, Madeli Participaties, PMV, Qbic, Sofinnova Partners